Bio-Path Holdings, Inc. (BPTH)
OTCMKTS
· Delayed Price · Currency is USD
0.164
-0.006 (-3.53%)
Mar 13, 2025, 1:01 PM EST
Bio-Path Holdings Employees
Bio-Path Holdings had 10 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
10
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,051,300
Market Cap
770.93K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
Longduoduo Company | 49 |
Bio-Path Holdings News
- 26 days ago - ARMISTICE CAPITAL, LLC Acquires Significant Stake in Bio-Path Holdings Inc - GuruFocus
- 4 weeks ago - Bio-Path Holdings Provides Key Clinical Updates - GlobeNewsWire
- 4 weeks ago - Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid Leukemia - GlobeNewsWire
- 2 months ago - Bio-Path Holdings Provides 2025 Clinical and Operational Update - GlobeNewsWire
- 3 months ago - Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients Enhances Insulin Sensitivity - GlobeNewsWire
- 3 months ago - Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 24 - Newsfile Corp
- 3 months ago - Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients - GlobeNewsWire
- 4 months ago - Bio-Path Holdings, Inc. (BPTH) Q3 2024 Earnings Call Transcript - Seeking Alpha